Treatment of COVID-19 Patients: Insights into the Use of Bone Marrow-Derived Mesenchymal Stem Cells

Patients with SARS-CoV-2 may be affected by the acute respiratory distress syndrome (ARDS), which has been associated with high mortality rate. As no specific drugs are available for ARDS, mesenchymal stem cells (MSC) seems to be a promising cell therapy due to immunomodulatory effects on reducing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, Heitor Duarte, Kondo, Andrea Tiemi, Kerbauy, Lucila, Paiva, Raquel de Melo Alves, Oliveira, Denise Cristine, Coa, Larissa Leggieri, Alvarez, Kelen Cristina Arcuri, Savioli, Mariana Lorenzi, Loureiro, Bruna Melo Coelho, Okamoto, Oswaldo Keith, Hamerschlak, Nelson, Kutner, Jose Mauro, Godoy, Juliana Aparecida Preto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
506.Hematopoiesis and Stem Cells: Microenvironment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701421/
http://dx.doi.org/10.1182/blood-2021-154291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701421/
http://dx.doi.org/10.1182/blood-2021-154291

Ejemplares similares